Table 4. Association of Antimicrobial Resistance Pattern and ESBL Genotypes.

	PER-1:16 (26.6%)			VEB: 9 (15%)
Antimicrobials	Resistant, No. (%)	Susceptible, No. (%)	Intermediate, No. (%)	Resistant, No. (%)	Susceptible, No. (%)	Intermediate, No. (%)
Amikacin	10 (62.5)	5 (31.25)	1(6.25)	5 (55.5)	2 (22.2)	2 (22.2)
Ceftazidime	12 (75)	4 (25)	0	9 (100)	0	0
Aztreonam	10 (62.5)	4 (25)	2 (12.5)	9 (100)	0	0
‍Cefepime	16 (100)	0	0	9 (100)	0	0
cefotaxime	87.5 (14)	0	2 (12.5)	9 (100)	0	0
Ciprofloxacin	2 (12.5)	13 ( 81.25)	1 (6.25)	2 (22.2)	6 (66.6)	1 (11.11)
Gentamicin	10(62.5)	6 ( 37.5 )	0	6 (66.6)	3 (33.3)	0
Imipenem	5 (31.25)	5 (31.25)	6 (37.5)	1 (11.11)	6 (66.6)	2 (22.2)
Meropenem	7 ( 43.75)	8 (50)	1 (6.25)	6 (66.6)	2 (22.2)	1 (11.11)
Ofloxacin	11 (68.8)	5 (31.25)	0	8 (88.8)	1 (11.11)	0
Piperacillin	16 (100)	0	0	9 (100)	0	0
Tobramycin	10 (62.5)	6 ( 37.5 )	0	6 (66.6)	3 (33.3)	0